Vinmac Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 99.57%
- Profit Growth 1394.37%
- Ebitda -56.54%
- Net Worth 44.12%
- Total Assets 59.60%
About Vinmac Pharmaceuticals
Vinmac Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2019 (Five years and 11 months 12 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vibhanshu Bansal, Vipin Mohan, and Vivek Seth serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2019PTC346277
-
Company No.
346277
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vinmac Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibhanshu Bansal
|
Director | 20-Feb-2019 | Current |
|
Vipin Mohan
|
Director | 20-Feb-2019 | Current |
|
Vivek Seth
|
Director | 20-Feb-2019 | Current |
Financial Performance of Vinmac Pharmaceuticals.
Vinmac Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 99.57% increase. The company also saw a substantial improvement in profitability, with a 1394.37% increase in profit. The company's net worth Soared by an impressive increase of 44.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinmac Pharmaceuticals?
Unlock access to Vinmac Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kshitiz Digital Services LlpVivek Seth is a mutual person
-
Hari Kripa Impex Private Limited
Vivek Seth is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vinmac Pharmaceuticals?
Unlock and access historical data on people associated with Vinmac Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinmac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinmac Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.